The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia
| Autor: | Flores, Andrew J., Bartlett, Mitchell J., Root, Brandon K., Parent, Kate L., Heien, Michael L., Porreca, Frank, Polt, Robin, Sherman, Scott J., Falk, Torsten |
|---|---|
| Zdroj: | In Neuropharmacology October 2018 141:260-271 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect